IP Library Granted Patent US 12,243,712
Granted Patent B2
US 12,243,712 · App. 18/365,146 · Granted Mar 4, 2025

Method and system for determining a charged particle beam exposure for a local pattern density

Inventors: Akira Fujimura (Saratoga, CA); Harold Robert Zable (Palo Alto, CA); Nagesh Shirali (San Jose, CA); Abhishek Shendre (Fremont, CA); William E. Guthrie (Santa Clara, CA); Ryan Pearman (San Jose, CA)
Assignee: D2S, Inc.
H01J37/3026G03F1/36G03F1/70G03F7/2061H01J37/3177H01J2237/31761H01J2237/31771H01J2237/31774H01J2237/31776
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,243,712
App. No.
18/365,146
Granted
Mar 4, 2025
Kind
B2
Abstract

Methods and systems for exposing a desired shape in an area on a surface using a charged particle beam system include determining a local pattern density for the area, based on an original set of exposure information. A pre-proximity effect correction (PEC) maximum dose for the local pattern density is determined, based on a pre-determined target post-PEC maximum dose. The pre-PEC maximum dose may be calculated near an edge of the desired shape. Methods also include modifying the original set of exposure information with the pre-PEC maximum dose to create a modified set of exposure information.

Claims (23)

1. A system for exposing a pattern in an area on a surface using a charged particle beam system, the system comprising:

a computer processor configured to determine a local pattern density for the area, based on an original set of exposure information;

a computer processor configured to determine a pre-proximity effect correction (PEC) maximum dose for the local pattern density, based on a pre-determined target post-PEC maximum dose; and

a computer processor configured to modify the original set of exposure information with the pre-PEC maximum dose to create a modified set of exposure information.

2. The system of claim 1 , wherein the pre-determined target post-PEC maximum dose is based on a maximum write time.

3. The system of claim 1 , wherein the modified set of exposure information is refined by PEC resulting in adjusted dosages that are less than the pre-determined target post-PEC maximum dose.

4. The system of claim 1 , further comprising a computer processor configured to determine an artificial background dose for the area, wherein the artificial background dose comprises an additional pattern with a sub-threshold exposure, and wherein the additional pattern is combined with the modified set of exposure information.

5. The system of claim 4 , further comprising a computer processor configured to calculate a backscatter for the area, based on the original set of exposure information, wherein in the area for which the calculated backscatter is less than a pre-determined threshold, the artificial background dose is a difference between the pre-determined threshold and the calculated backscatter.

6. The system of claim 4 , wherein the system is configured to perform a mask exposure inline with one or more steps selected from the group consisting of determining the local pattern density, determining the pre-PEC maximum dose, determining the artificial background dose, and creating the modified set of exposure information.

7. A system for exposing a desired shape in an area on a surface using a charged particle beam system, the system comprising:

a computer processor configured to determine a local pattern density for the area, based on an original set of exposure information;

a computer processor configured to determine a pre-proximity effect correction (PEC) maximum dose for the local pattern density, based on a pre-determined target post-PEC maximum dose, wherein the pre-PEC maximum dose is calculated near an edge of the desired shape; and

a computer processor configured to modify the original set of exposure information with the pre-PEC maximum dose to create a modified set of exposure information.

8. The system of claim 7 , wherein the pre-determined target post-PEC maximum dose is based on a maximum write time.

9. The system of claim 7 , wherein the modified set of exposure information is refined by PEC resulting in adjusted dosages that are less than the pre-determined target post-PEC maximum dose.

10. The system of claim 7 , wherein a portion of a width of the desired shape exceeds a pre-determined width.

11. The system of claim 7 , wherein at a location where a width of a portion of the desired shape is below a pre-determined width, the pre-PEC maximum dose is calculated near a center of the desired shape.

12. The system of claim 7 , further comprising a computer processor configured to calculate a backscatter for a sub area of the area, based on the local pattern density for the area.

13. The system of claim 12 , wherein the computer processor configured to calculate the backscatter for the sub area of the area is configured to increase a dosage for at least one pixel in a plurality of pixels in the sub area, in a location where the backscatter of the sub area is below a pre-determined threshold, thereby increasing the backscatter of the sub area.

14. The system of claim 13 , wherein the dosage for the at least one pixel in the plurality of pixels in the sub area is increased so that the backscatter is increased to a pre-determined value.

15. The system of claim 13 , wherein the dosage for the at least one pixel in the plurality of pixels in the sub area is increased only if the at least one pixel is more than a pre-determined distance from the edge of the desired shape in the area on the surface.

16. The system of claim 13 , wherein the increased dosage of the at least one pixel in the plurality of pixels in the sub area is applied closer than a pre-determined distance from an inner edge of the desired shape in the area on the surface.

17. The system of claim 13 , wherein the increase in the dosage comprises an artificial background dose.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 4, 2023
From: FUJIMURA, AKIRA; ZABLE, HAROLD ROBERT; SHIRALI, NAGESH; SHENDRE, ABHISHEK; GUTHRIE, WILLIAM E.; PEARMAN, RYAN
To: D2S, INC.
Reel/Frame 064491/0959 →
Continuity (5)
Continuation 18068293 · Dec 19, 2022
Continuation In Part 17304307 · Jun 17, 2021
Continuation In Part 16934281 · Jul 21, 2020
Continuation 16422269 · May 24, 2019
Related Publication 20230386784A1 · Nov 30, 2023
References Cited (96)
US 4463265A · Owen et al. · 1984 [cited by applicant]
US 5451487A · Abe et al. · 1995 [cited by applicant]
US 5510214A · Pan et al. · 1996 [cited by applicant]
US 5582938A · Ham · 1996 [cited by applicant]
US 5847959A · Veneklasen et al. · 1998 [cited by applicant]
US 5885748A · Ohnuma · 1999 [cited by applicant]
US 6528806B1 · Kawamura · 2003 [cited by applicant]
US 6872507B2 · Tzu et al. · 2005 [cited by applicant]
US 7241542B2 · Hudek et al. · 2007 [cited by applicant]
US 8062813B2 · Zable et al. · 2011 [cited by applicant]
US 8137871B2 · Zable et al. · 2012 [cited by applicant]
US 8221939B2 · Zable et al. · 2012 [cited by applicant]
US 8221940B2 · Zable et al. · 2012 [cited by applicant]
US 9038003B2 · Pearman et al. · 2015 [cited by applicant]
US 9043734B2 · Fujimura et al. · 2015 [cited by applicant]
US 9057956B2 · Fujimura et al. · 2015 [cited by applicant]
US 9343267B2 · Fujimura et al. · 2016 [cited by applicant]
US 9612530B2 · Fujimura et al. · 2017 [cited by applicant]
US 9625809B2 · Fujimura et al. · 2017 [cited by applicant]
US 10478744B2 · Meyer · 2019 [cited by examiner]
US 10522329B2 · Platzgummer et al. · 2019 [cited by applicant]
US 10748744B1 · Fujimura et al. · 2020 [cited by applicant]
US 11062878B2 · Fujimura · 2021 [cited by examiner]
US 11756765B2 · Fujimura · 2023 [cited by examiner]
US 20020148978A1 · Innes et al. · 2002 [cited by applicant]
US 20030124442A1 · Yang · 2003 [cited by applicant]
US 20040011966A1 · Sasaki et al. · 2004 [cited by applicant]
US 20040178366A1 · Ando et al. · 2004 [cited by applicant]
US 20060183025A1 · Yang et al. · 2006 [cited by applicant]
US 20080168419A1 · Burkhardt et al. · 2008 [cited by applicant]
US 20080203324A1 · Fujimura et al. · 2008 [cited by applicant]
US 20090181551A1 · Tan et al. · 2009 [cited by applicant]
US 20100055586A1 · Fujimura et al. · 2010 [cited by applicant]
US 20120094219A1 · Fujimura et al. · 2012 [cited by applicant]
US 20120219886A1 · Fujimura et al. · 2012 [cited by applicant]
US 20120221981A1 · Fujimura et al. · 2012 [cited by applicant]
US 20130205264A1 · Fujimura et al. · 2013 [cited by applicant]
US 20130283216A1 · Pearman et al. · 2013 [cited by applicant]
US 20130288181A1 · Sugiyama · 2013 [cited by applicant]
US 20130309610A1 · Zable et al. · 2013 [cited by applicant]
US 20140007023A1 · Shin et al. · 2014 [cited by applicant]
US 20140138527A1 · Kato et al. · 2014 [cited by applicant]
US 20160195805A1 · Fujimura et al. · 2016 [cited by applicant]
US 20160252807A1 · Manakli et al. · 2016 [cited by applicant]
US 20160276132A1 · Platzgummer et al. · 2016 [cited by applicant]
US 20160349626A1 · Matsumoto · 2016 [cited by applicant]
US 20170124247A1 · Fujimura et al. · 2017 [cited by applicant]
US 20170139327A1 · Nomura · 2017 [cited by applicant]
US 20170278672A1 · Suganuma et al. · 2017 [cited by applicant]
US 20190066976A1 · Platzgummer et al. · 2019 [cited by applicant]
US 20190304748A1 · Yoshikawa et al. · 2019 [cited by applicant]
US 20200098545A1 · Chang et al. · 2020 [cited by applicant]
CN 1530755A · 2004 [cited by applicant]
CN 103488042A · 2014 [cited by applicant]
CN 103858211A · 2014 [cited by applicant]
EP 1429368A2 · 2004 [cited by applicant]
EP 3264442A1 · 2018 [cited by applicant]
JP H07297094A · 1995 [cited by applicant]
JP H10055958A · 1998 [cited by applicant]
JP 2003338460A · 2003 [cited by applicant]
JP H08321462A · 2003 [cited by applicant]
JP 2005019426A · 2005 [cited by applicant]
JP 2013115226A · 2013 [cited by applicant]
JP 2013219288A · 2013 [cited by applicant]
JP 2013229512A · 2013 [cited by applicant]
JP 2010098275A · 2014 [cited by applicant]
JP 2014512670 · 2014 [cited by applicant]
JP 2014512670A · 2014 [cited by applicant]
JP 2014530494A · 2014 [cited by applicant]
JP 2016174152A · 2016 [cited by applicant]
JP 2018107179A · 2020 [cited by applicant]
JP 7474787B2 · 2024 [cited by applicant]
KR 1020150142900A · 2015 [cited by applicant]
TW 201142904A · 2011 [cited by applicant]
TW 201717244B · 2018 [cited by applicant]
Geraint Owen et al., “Proximity effect correction for electron beam lithography by equalization of background dose,” Journal of Applied Physics, vol. 54, Issue 6, Jun. 1983. [cited by applicant]
International Search Report dated Apr. 13, 2020 for PCT Patent Application No. PCT/IB2019/060968. [cited by applicant]
International Search Report dated Aug. 18, 2020 for PCT Patent Application No. PCT/IB2020/054546. [cited by applicant]
Klimpel, T. et al., “Proximity effect correction optimizing image quality and writing time for an electron multi-beam mask writer,” Proc. SPIE vol. 8522, Nov. 8, 2012. [cited by applicant]
Mack, Chris A. et al., “Electron-beam lithography simulation for maskmaking, part V: Impact of GHOST proximity effect correction on process window”, SPIE vol. 3873, pp. 2-20, Dec. 30, 1999. [cited by applicant]
Notice of Allowance and Fees dated Jul. 7, 2023 for U.S. Appl. No. 17/304,307. [cited by applicant]
Notice of Allowance dated Apr. 22, 2020 for U.S. Appl. No. 16/422,269. [cited by applicant]
Notice of Allowance dated Mar. 15, 2021 for U.S. Appl. No. 16/934,281. [cited by applicant]
Notice of Allowance dated Sep. 1, 2020 for U.S. Appl. No. 16/231,447. [cited by applicant]
Office Action dated Dec. 8, 2020 for U.S. Appl. No. 16/934,281. [cited by applicant]
Office Action dated Jun. 20, 2023 for U.S. Appl. No. 18/168,772. [cited by applicant]
Office Action dated Mar. 1, 2023 for U.S. Appl. No. 17/304,307. [cited by applicant]
Office Action dated May 29, 2020 for U.S. Appl. No. 16/231,447. [cited by applicant]
Office Action dated Nov. 10, 2021 for Austria Patent Application No. A9484/2019. [cited by applicant]
Office Action dated Nov. 24, 2021 for U.S. Appl. No. 17/135,400. [cited by applicant]
Official Letter and Search Report dated Aug. 21, 2023 for Taiwan Patent Application No. 108146715. [cited by applicant]
Official Letter and Search Report dated Sep. 28, 2023 for Taiwan Patent Application No. 109116592. [cited by applicant]
Office Action dated Apr. 16, 2024 for Japan Patent Application No. 2021-535205. [cited by applicant]
Office Action dated Nov. 21, 2023 for Japan Patent Application No. 2021-535205. [cited by applicant]
Office Action dated Sep. 17, 2024 for Japan Patent Application No. 2021-535205. [cited by applicant]
Office Action dated Dec. 24, 2024 for Japan Patent Application No. 2024-065404. [cited by applicant]